For young individuals with cancer, residence in redlined neighborhoods is associated with lower survival at 5 and 10 years.

The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

Obesity was associated with improved overall survival (OS) after curative resection in patients with non-small cell lung cancer (NSCLC), particularly those who did not have low sk ...

Researchers have identified two microRNA that may predict which individuals with cancer are at elevated risk for ...

Can pollution cause it? What about inflammation? And how do tumors spread? Here’s what scientists are learning about this ...

The addition of trastuzumab and pertuzumab to chemotherapy was associated with increased toxicity in patients with ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

Young cancer patients have a 62% increased risk of dying if they live in a previously “redlined” residential area, ...

“Studies have shown that healthcare utilization at the end of life is high, and patients receive aggressive medical care that ...

First-line maintenance (1LM) niraparib significantly extends progression-free survival (rwPFS) and time to next treatment ...

Experts say two to three times weekly can be an optimal regimen, and 12 international researchers' work may inspire you to ...

Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.